[HTML][HTML] Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches

M Ashrafizadeh, M Delfi, A Zarrabi, A Bigham… - Journal of controlled …, 2022 - Elsevier
The site-specific delivery of antitumor agents is of importance for providing effective cancer
suppression. Poor bioavailability of anticancer compounds and the presence of biological …

Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape

S Raikwar, A Jain, S Saraf, PD Bidla… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Breast carcinoma (BC) is one of the most frequent causes of cancer-related
death among women, which is due to the poor response to conventional therapy. There are …

A Perspective of Engineered Lipids and Liposomes: Chemical Design and Functional Application Based on Therapeutic Safety

S Li, W Wang, X Yu - Chemistry of Materials, 2023 - ACS Publications
Liposome-based drugs have emerged as highly successful nanomedicines for clinical
applications owing to their excellent biocompatibility, biodegradability, and targeting effects …

Doxorubicin bearing peptide anchored PEGylated PLGA nanoparticles for the effective delivery to prostate cancer cells

PK Panda, SK Jain - Journal of Drug Delivery Science and Technology, 2023 - Elsevier
Novel peptide-conjugated doxorubicin-loaded PEGylated PLGA nanoparticles (CPDNPs)
were developed for prolonged and effective delivery to prostate cancer (PCa) cells …

Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization, in vitro and in vivo assessment

S Raikwar, V Yadav, S Jain, SK Jain - Journal of Liposome …, 2024 - Taylor & Francis
The object of the current study was to develop and evaluate trastuzumab-conjugated
Paclitaxel (PTX) and Elacridar (ELA)-loaded PEGylated pH-sensitive liposomes (TPPLs) for …

Hyaluronic acid functionalized liposomes embedded in biodegradable beads for duo drugs delivery to oxaliplatin-resistant colon cancer

A Tiwari, V Gajbhiye, A Jain, A Verma, A Shaikh… - Journal of Drug Delivery …, 2022 - Elsevier
Background Oxaliplatin (OHP) resistance is a major hurdle in the chemotherapeutic
treatment of colorectal cancer (CRC). The present study aimed to formulate Eudragit S-100 …

An insight into anticancer bioactives from Punica granatum (Pomegranate)

K Sharma, P Kesharwani, SK Prajapati… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Cancer is one of the major reasons for mortality across the globe. Many side-effects are
associated with the formulations available in the market, affecting the quality of life of the …

Bovine serum albumin-Camptothecin nanoparticles for RNAs packaging to improve the prognosis of Cancer

Y Song, H Liu, N Zhao, J Chen, X Zhang… - International Journal of …, 2024 - Elsevier
Abstract xRNAs have received a lot of attention for their potential in targeted therapy. This
study aims to construct nanoparticles using bovine serum albumin (BSA) and Camptothecin …

Mucoadhesive gastroretentive microparticulate system for programmed delivery of famotidine and clarithromycin

A Srivastava, A Verma, S Saraf, A Jain… - Journal of …, 2021 - Taylor & Francis
Aim The present research was aimed to develop thiolated polyacrylic acid (TPA) based
microspheres (MSPs) containing famotidine (FX) and clarithromycin (CLX). Methods TPA …

FIS103, a Novel SULT1A1-dependent Prodrug, Demonstrates Potent Antitumor Activity in Renal Cell Carcinoma

RA Hamilton, U Saini, M Tran, CJ Foley, P Enagala… - medRxiv, 2024 - medrxiv.org
Intra-tumoral heterogeneity has been shaping the field of precision medicine for cancer
patients ever since its emergence. Prodrugs, which require activation by tumor associated …